This page contains recent news articles, when available, and an overview of but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on

Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex  -  Mar 10, 2008
CNNMoney.comAt the recommended dosage, IV Busulfex produced profound myelosuppression in all patients (ie, severe granulocytopenia, thrombocytopenia, anemia,

Otsuka Pharmaceutical Acquires Rights to IV Busulfex from PDL ...  -  Dec 17, 2007
CNNMoney.comAt the recommended dosage, IV Busulfex produced profound myelosuppression in all patients (ie, severe granulocytopenia, thrombocytopenia, anemia,

Compass Healthcare Communications Announces Relaunch of Infergen ...  -  10 Aug 2007
PharmaLive.com (press release),...anorexia (24%), injection site erythema (23%), granulocytopenia (23%), dizziness (22%), cough (22%), dyspepsia (21%), thrombocytopenia (19%),

Azur Pharma Announces the Acquisition of FazaClo for $42 Million ...  -  Jul 3, 2007
CNW Telbec (Communiqués de presse),FazaClo requires a Patient Registry because of the risk of rare, but severe adverse events such as agranulocytosis and granulocytopenia associated with the

Clinical Data Suggest Potential Versatility of ALIMTA(R ...  -  Jun 3, 2007
PipelineReview.com (press release),89, p < .001), and; granulocytopenia or a lowering of granulocyte white blood cells (78 vs. 98, p=.02). More patients in the GEMZAR arm received transfusion

New Data Show Oral Valcyte(R) (valganciclovir) as Effective as iv ...  -  May 9, 2007
campus med,The clinical toxicity of Valcyte, which is metabolised to ganciclovir, includes granulocytopenia, anaemia and thrombocytopenia.

New Data Show Oral Valcyte(R) (valganciclovir) as Effective as iv ...  -  May 9, 2007
Juraforum.de,The clinical toxicity of Valcyte, which is metabolised toganciclovir, includes granulocytopenia, anaemia and thrombocytopenia.In animal studies, ganciclovir

Mycamine™ Equivalent to Ambisome® with Less Side Effects for ...  -  May 9, 2007
Cancer Consultants (press release),Fungal infections are a common complication of cancer treatment due to granulocytopenia and immunosuppression. The mainstay of prevention and treatment of

Avanir Receives FDA Approvable Letter for New Formulation of ...  -  Jan 31, 2007
PharmaLive.com (press release),Because of the risk of agranulocytosis and granulocytopenia associated with the use of clozapine, Avanir maintains the FazaClo Patient Registry.

Case 2-2007 — A 49-Year-Old Woman with a Pigmented Lesion on the Arm  -  Jan 17, 2007
New England Journal of Medicine (subscription),20 to 40% of patients report marked constitutional symptoms, evidence of transient hepatotoxicity develops in 20%, and 40% have marked granulocytopenia.

Trial Data Showed Eltrombopag Decreased Bleeding Episodes And ...  -  Dec 16, 2006
Medical News Today (press release),...[viii] Mocharnuk R. Growth factors in granulocytopenia and thrombocytopenia. Presented 44th Annual Meeting of the American Society of Hematology meeting,

ASH: Rituximab Plus CHOP Improves Survival of Indolent Lymphoma in ...  -  Dec 12, 2006
MedPage Today,Toxicities, including reduced hemoglobin, granulocytopenia, thrombocytopenia, infections and nausea, were similar in both groups.

Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study  -  Dec 12, 2006
Genetic Engineering News (press release),...anorexia (24%), injection site erythema (23%), granulocytopenia (23%), dizziness (22%), cough (22%), dyspepsia (21%), thrombocytopenia (19%),

ASH: Rituximab Plus CHOP Improves Survival of Indolent Lymphoma in ...  -  Dec 12, 2006
MedPage Today,Toxicities, including reduced hemoglobin, granulocytopenia, thrombocytopenia, infections and nausea, were similar in both groups. ...

Valeant Pharmaceuticals Initiates Infergen® Phase 4 Study  -  Dec 12, 2006
Business Wire (press release),31%), infection upper respiratory (31%), diarrhea (29%), depression (26%), anorexia (24%), injection site erythema (23%), granulocytopenia (23%), dizziness (22 ...

Trial Data Showed Promacta(TM) (Eltrombopag) Decreased Bleeding ...  -  Dec 11, 2006
PR Newswire (press release),...(7) http://www.nlm.nih.gov/medlineplus/ency/article/003647.htm. Accessed Oct 19 2006. (8) Mocharnuk R. Growth factors in granulocytopenia and thrombocytopenia. ...

Search the web for more resources on

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.